Company overview
Basic information
Company name
Ossu, MB
Company code
305901126
Registered address
Panevėžys, Kranto g. 23-4, LT-35172
Registration date
2021-09-17
Company age: 5 y.
Contact information
Edit data
Phone
Email
Not disclosed
(personal)
Website
https://www.ossu.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
MB Ossu
Company code: 305901126
Address: Panevėžys, Kranto g. 23-4, LT-35172
Download a detailed company report
Make confident decisions with all the information about Ossu, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Ossu, MB (company code 305901126) is an operational private small partnership registered on 17 September 2021. It is classified as a micro company operating in the national private non-financial companies sector, under private ownership in which Lithuanian natural and legal persons hold more than 50% of the authorised capital and no foreign investor capital is included. Governance is listed as CEO only. The company is based in Panevežys, Kranto g. 23-4, in Panevežio m. sav., Panevežio apskr. Its activity is classified under EVRK code G.47.73.00, retail sale of pharmaceutical products.
In financial year 2025, the company generated revenue of €6.2K, compared with €6.4K in 2024 and €2.9K in 2023. Net profit in 2025 was €3.1K, following €3.3K in 2024 and €1.4K in 2023. Profit margin remained close to one half of revenue, at 49.8% in 2025 and 50.7% in 2024. Total assets increased to €7.9K at the end of 2025, while equity rose to €7.4K and liabilities were €477. Revenue declined by 2.9% year on year in 2025, but was still more than double the 2023 level.
In financial year 2025, the company generated revenue of €6.2K, compared with €6.4K in 2024 and €2.9K in 2023. Net profit in 2025 was €3.1K, following €3.3K in 2024 and €1.4K in 2023. Profit margin remained close to one half of revenue, at 49.8% in 2025 and 50.7% in 2024. Total assets increased to €7.9K at the end of 2025, while equity rose to €7.4K and liabilities were €477. Revenue declined by 2.9% year on year in 2025, but was still more than double the 2023 level.